Page last updated: 2024-10-30

kynurenic acid and Multiple Myeloma

kynurenic acid has been researched along with Multiple Myeloma in 2 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zdzisińska, B1
Wejksza, K1
Walter-Croneck, A1
Turski, WA1
Kandefer-Szerszeń, M1
CREPALDI, G1
PARPAJOLA, A1

Other Studies

2 other studies available for kynurenic acid and Multiple Myeloma

ArticleYear
Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Leukemia research, 2010, Volume: 34, Issue:1

    Topics: Adult; Aged; Bone Marrow; Female; Humans; Immunohistochemistry; Kynurenic Acid; Male; Middle Aged; M

2010
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
    Clinica chimica acta; international journal of clinical chemistry, 1964, Volume: 9

    Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky

1964